Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Tindall

Showing results (81-90 of 571) with videos related to

Pageof 58
Sort By:
Mayo Clinic Proceedings|January 1, 2010
New developments in the medical management of prostate cancerManish Kohli, Donald J Tindall
International Journal of Systematic and Evolutionary Microbiology|March 31, 2009
Hans Georg Truper, life member of the ICSP - an appreciationPeter Kämpfer, Brian J Tindall,
Plos Computational Biology|May 10, 2014
Modelling negative feedback networks for activating transcription factor 3 predicts a dominant role for miRNAs in immediate early gene regulationMarcus J Tindall, Angela Clerk
Oncogene|April 9, 2008
FOXOs, cancer and regulation of apoptosisZ Fu, D J Tindall
Biochimica Et Biophysica Acta|January 18, 2011
Regulation of FOXO protein stability via ubiquitination and proteasome degradationHaojie Huang, Donald J Tindall
Cell Cycle (Georgetown, Tex.)|April 26, 2007
CDK2 and FOXO1: a fork in the road for cell fate decisionsHaojie Huang, Donald J Tindall
Bulletin of Mathematical Biology|November 7, 2006
Modelling cell growth and its modulation of the G1/S transitionT Alarcón, M J Tindall
Journal of Cell Science|July 25, 2007
Dynamic FoxO transcription factorsHaojie Huang, Donald J Tindall
Methods in Molecular Biology (Clifton, N.J.)|July 29, 2011
Androgen action during prostate carcinogenesisDiping Wang, Donald J Tindall
The Journal of Biological Chemistry|July 28, 2006
Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cellsScott M Dehm, Donald J Tindall
Pageof 58

Showing results (81-90 of 571) with videos related to

Sort By:
Pageof 58
Mayo Clinic Proceedings|January 1, 2010
New developments in the medical management of prostate cancerManish Kohli, Donald J Tindall
International Journal of Systematic and Evolutionary Microbiology|March 31, 2009
Hans Georg Truper, life member of the ICSP - an appreciationPeter Kämpfer, Brian J Tindall,
Plos Computational Biology|May 10, 2014
Modelling negative feedback networks for activating transcription factor 3 predicts a dominant role for miRNAs in immediate early gene regulationMarcus J Tindall, Angela Clerk
Oncogene|April 9, 2008
FOXOs, cancer and regulation of apoptosisZ Fu, D J Tindall
Biochimica Et Biophysica Acta|January 18, 2011
Regulation of FOXO protein stability via ubiquitination and proteasome degradationHaojie Huang, Donald J Tindall
Cell Cycle (Georgetown, Tex.)|April 26, 2007
CDK2 and FOXO1: a fork in the road for cell fate decisionsHaojie Huang, Donald J Tindall
Bulletin of Mathematical Biology|November 7, 2006
Modelling cell growth and its modulation of the G1/S transitionT Alarcón, M J Tindall
Journal of Cell Science|July 25, 2007
Dynamic FoxO transcription factorsHaojie Huang, Donald J Tindall
Methods in Molecular Biology (Clifton, N.J.)|July 29, 2011
Androgen action during prostate carcinogenesisDiping Wang, Donald J Tindall
The Journal of Biological Chemistry|July 28, 2006
Ligand-independent androgen receptor activity is activation function-2-independent and resistant to antiandrogens in androgen refractory prostate cancer cellsScott M Dehm, Donald J Tindall
Pageof 58